A_randomized_trial_of_amsacrine_and_rubidazone_in_39_patients_with_acute_promyelocytic_leukemia._Thirty-nine_patients_with_untreated_acute_promyelocytic_leukemia_(APL)_were_randomly_allocated_to_receive_rubidazone_(zorubicin)_200_mg/m2/d,_days_1_to_4_plus_cytarabine_(Ara_C)_200_mg/m2/d,_days_1_to_7_(arm_A,_21_patients),_or_amsacrine_(Amsa)_150_mg/m2/d,_days_1_to_4_plus_Ara_C_200_mg/m2/d,_days_1_to_7_(arm_B,_18_patients)._Prophylaxis_of_disseminated_intravascular_coagulation_was_made_by_platelet_transfusions_and_heparin._In_case_of_leukemic_resistance,_patients_received_a_second_course_with_2_days_of_rubidazone_(arm_A)_or_Amsa_(arm_B)_and_3_days_of_Ara_C._Patients_who_achieved_complete_remission_(CR)_received_three_consolidation_courses_with_the_two_drugs_used_for_induction_and_maintenance_therapy_for_3_years._Two_patients_in_arm_A_and_one_in_arm_B_were_allografted_in_first_CR._Initial_characteristics_were_similar_in_both_arms._In_arm_A,_18_patients_(86%)_reached_CR,_two_had_hypoplastic_death,_and_one_had_leukemic_resistance_after_two_courses._In_arm_B,_12_patients_(66%)_achieved_CR,_two_had_early_death_(CNS_bleeding,_one_case;_ventricular_fibrillation,_one_case),_and_four_had_resistant_leukemia_after_two_courses._The_difference_in_CR_rate_between_the_two_arms_was_not_significant._In_arm_A,_disease-free_survival_(DFS)_showed_a_plateau_at_54.3%_after_34_months_(95%_confidence_interval_CI,_32.1%_to_74.9%),_with_eight_CRs_longer_than_34_months._In_arm_B,_DFS_was_significantly_shorter_(P_less_than_.03),_showing_a_plateau_at_16.7%_after_38_months_(95%_confidence_interval,_4.7%_to_44.6%),_and_only_two_prolonged_CRs_were_seen._The_difference_in_DFS_remained_significant_after_censoring_allografted_patients_and_patients_who_died_in_CR_(one_in_arm_A,_two_in_arm_B)._Our_results_suggest_that_Amsa-Ara_C_combinations_may_be_inferior_to_anthracycline-Ara_C_combinations_in_the_treatment_of_APL,_because_they_seem_to_provide_shorter_DFS_and,_possibly,_a_higher_incidence_of_initial_leukemic_resistance._However,_studies_with_larger_numbers_of_patients_are_required.